US Merck Products

Filter by brand or generic name

Showing 21 of 21 products

#00857c
(suvorexant) 5, 10, 15, 20 mg tablets, for oral use, C-IV
- Prescribing information
- Medication guide
Product Information
(suvorexant) 5, 10, 15, 20 mg tablets, for oral use, C-IV
#00857c
(sugammadex) injection 100 mg/mL (equivalent to 108.8 mg/mL sugammadex sodium), for intravenous use
- Prescribing information
Product Information
(sugammadex) injection 100 mg/mL (equivalent to 108.8 mg/mL sugammadex sodium), for intravenous use
#00857c
(fidaxomicin) tablets 200 mg | oral suspension 200 mg/5 ml
- Prescribing information
- Patient information
Product Information
(fidaxomicin) tablets 200 mg | oral suspension 200 mg/5 ml
var(–colorPrimary)
(doravirine 100 mg/islatravir 0.25 mg) tablets
- Prescribing information
- Patient information
Product Information
(doravirine 100 mg/islatravir 0.25 mg) tablets
#00857c
ISENTRESS® (raltegravir 400 mg) film-coated tablets, for oral use; chewable tablets, for oral use; oral suspension and ISENTRESS® HD (raltegravir 600 mg) film-coated tablets, for oral use
Product Information
ISENTRESS® (raltegravir 400 mg) film-coated tablets, for oral use; chewable tablets, for oral use; oral suspension and ISENTRESS® HD (raltegravir 600 mg) film-coated tablets, for oral use
#00857c
JANUMET® (sitagliptin and metformin HCI) 50/500 mg, 50/1000 mg tablets and JANUMET® XR (sitagliptin and metformin HCI extended-release) 50/500 mg, 50/1000 mg, 100/1000 mg tablets
- Prescribing information
- Medication guide
Product Information
JANUMET® (sitagliptin and metformin HCI) 50/500 mg, 50/1000 mg tablets and JANUMET® XR (sitagliptin and metformin HCI extended-release) 50/500 mg, 50/1000 mg, 100/1000 mg tablets
Before prescribing JANUMET or JANUMET XR, please read the Prescribing Information, including the Boxed Warning about lactic acidosis.
#00857c
(sitagliptin) 25 mg, 50 mg, 100 mg tablets
- Prescribing information
- Medication guide
Product Information
(sitagliptin) 25 mg, 50 mg, 100 mg tablets
#00857c
(enlicitide) tablets 20 mg
- Prescribing information
- Patient information
Product Information
(enlicitide) tablets 20 mg
#00857c
(ensifentrine) inhalation suspension 3 mg/2.5 mL
Product Information
(ensifentrine) inhalation suspension 3 mg/2.5 mL
#00857c
PIFELTRO® (doravirine 100 mg) tablets and DELSTRIGO® (doravirine 100 mg/lamivudine 300 mg/tenofovir disoproxil fumarate 300 mg) tablets
- Prescribing information
- Patient information
Product Information
PIFELTRO® (doravirine 100 mg) tablets and DELSTRIGO® (doravirine 100 mg/lamivudine 300 mg/tenofovir disoproxil fumarate 300 mg) tablets
Before prescribing PIFELTRO, please read the accompanying Prescribing Information. The Patient Information also is available.

Before prescribing DELSTRIGO, please read the accompanying Prescribing Information, including the Boxed Warning about posttreatment acute exacerbation of Hepatitis B. The Patient Information also is available.
#00857c
PREVYMIS® (letermovir) 240 mg, 480 mg tablets / Injection 20 mg/mL / Oral pellets 20 mg, 120 mg per packet
Product Information
PREVYMIS® (letermovir) 240 mg, 480 mg tablets / Injection 20 mg/mL / Oral pellets 20 mg, 120 mg per packet
#00857c
(imipenem, cilastatin, and relebactam) for injection 1.25 g
- Prescribing information
Product Information
(imipenem, cilastatin, and relebactam) for injection 1.25 g
#00857c
(ertugliflozin and metformin HCI) 2.5 mg/500 mg, 2.5 mg/1000 mg, 7.5 mg/500 mg, 7.5 mg/1000 mg tablets
- Prescribing information
- Medication guide
Product Information
(ertugliflozin and metformin HCI) 2.5 mg/500 mg, 2.5 mg/1000 mg, 7.5 mg/500 mg, 7.5 mg/1000 mg tablets
Before prescribing SEGLUROMET, please read the Prescribing Information, including the Boxed Warning about lactic acidosis.
#00857c
(tedizolid phosphate) 200 mg injection, for intravenous use; 200 mg tablet, for oral use
- Prescribing information
- Patient information
Product Information
(tedizolid phosphate) 200 mg injection, for intravenous use; 200 mg tablet, for oral use
#00857c
(ertugliflozin) 5 mg, 15 mg tablets
- Prescribing information
- Medication guide
Product Information
(ertugliflozin) 5 mg, 15 mg tablets
#00857c
(ertugliflozin and sitagliptin) 5 mg/100 mg, 15 mg/100 mg tablets
- Prescribing information
- Medication guide
Product Information
(ertugliflozin and sitagliptin) 5 mg/100 mg, 15 mg/100 mg tablets
#00857c
(vericiguat) tablets 2.5 mg, 5 mg, 10 mg
- Prescribing information
- Medication guide
Product Information
(vericiguat) tablets 2.5 mg, 5 mg, 10 mg
Before prescribing VERQUVO, please read the Prescribing Information, including the Boxed Warning about embryo-fetal toxicity.
#00857c
(belzutifan) 40 mg tablets
- Prescribing information
- Medication guide
Product Information
(belzutifan) 40 mg tablets
Before prescribing WELIREG, please read the Prescribing Information, including the Boxed Warning about embryo-fetal toxicity.
var(–colorPrimary)
(sotatercept-csrk) for injection 45 mg, 60 mg
Product Information
(sotatercept-csrk) for injection 45 mg, 60 mg
#00857c
(ceftolozane and tazobactam) for injection (1.5 g), for intravenous use
- Prescribing information
Product Information
(ceftolozane and tazobactam) for injection (1.5 g), for intravenous use
#00857c
(bezlotoxumab) injection 25 mg/mL
- Prescribing information
- Patient information
Product Information
(bezlotoxumab) injection 25 mg/mL

BELSOMRA®

BRIDION®

DIFICID®

IDVYNSO™

ISENTRESS® & ISENTRESS® HD

JANUMET® & JANUMET® XR

JANUVIA®

LIPFENDRA®

OHTUVAYRE®

PIFELTRO® & DELSTRIGO®

PREVYMIS®

RECARBRIO™

SEGLUROMET®

SIVEXTRO®

STEGLATRO®

STEGLUJAN®

VERQUVO®

WELIREG®

WINREVAIR™

ZERBAXA®

ZINPLAVA™